Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Leukemia Therapeutics Market Report 2024

Leukemia Therapeutics Global Market Report 2025 – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia), By Molecule Type (Small Molecules, Biologics), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Leukemia Therapeutics Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Leukemia Therapeutics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Leukemia Therapeutics Market Definition

Leukemia therapeutics refer to a treatment used to treat an aggressive (quickly spreading) malignancy in which the blood or bone marrow contain an excessive amount of myeloblasts (immature white blood cells). The type treatment for leukemia depends on various factors such as age, overall health, type of leukemia, its current condition within the body and others.

The main treatment types in leukemia therapeutics are chemotherapy, immunotherapy, targeted therapy, and other treatments. Immunotherapy is a method of leukemia treatment that stimulates the body's immune system to recognize and eliminate malignant cells. These are used to treat acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, and other types of leukemia using small molecules and biologics. The various end users of leukemia therapeutics are hospitals, homecare, specialty clinics, and other end-users.

Leukemia Therapeutics Market Segmentation

The leukemia therapeutics market covered in this report is segmented –

1) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments

2) By Type Of Leukemia: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia

3) By Molecule Type: Small Molecules, Biologics

4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Plant Alkaloids, Corticosteroids

2) By Immunotherapy: Monoclonal Antibodies, CAR T-Cell Therapy, Immune Checkpoint Inhibitors, Vaccines

3) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), BCL-2 Inhibitors, IDH Inhibitors, Other Targeted Agents

4) By Other Treatments: Radiation Therapy, Stem Cell Transplantation, Supportive Care Treatments

Leukemia Therapeutics Market Size and growth rate 2025 to 2029: Graph

Leukemia Therapeutics Market Size 2025 And Growth Rate

The leukemia therapeutics market size has grown strongly in recent years. It will grow from $17.57 billion in 2024 to $18.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to growth in geriatric population, improved diagnostics leading to early detection of leukemia, increasing prevalence of leukemia, growing investment in research and development, expansion of personalized medicine approaches.

Leukemia Therapeutics Market Growth Forecast

The leukemia therapeutics market size is expected to see strong growth in the next few years. It will grow to $25.91 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to development of novel immunotherapies for leukemia, growing focus on precision medicine in leukemia treatment, expansion of indications for existing leukemia therapies, increased adoption of gene therapies, advances in supportive care for leukemia patients. Major trends in the forecast period include integration of biomarker-driven approaches, rise of combination therapies for enhanced efficacy, emphasis on minimal residual disease monitoring, increasing use of car-t cell therapies, exploration of targeted therapies based on leukemia subtypes.

Book your 30 minutes free consultation with our research experts

Contact Us

Leukemia Therapeutics Market Driver: The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market

The rising prevalence of leukemia is driving the growth of the leukemia therapeutics market. Leukemia is a type of blood cancer that starts in the bone marrow and proceeds to uncontrolled blood cell growth. The increased accessibility of medical treatment to leukemia patients across the globe and the growing availability of treatment options have contributed to increased demand for leukemia therapeutics. For instance, in January 2023, according to a report published by the American Cancer Society, a US-based health organization, it is anticipated that there will be around 59,610 new instances of leukemia of all types and approximately 23,710 fatalities in 2023 resulting from leukemia of all types in the United States. Additionally, an estimated 20,380 new cases of acute myeloid leukemia (AML) and about 11,310 AML-related deaths are expected in the same year. Therefore, the rising prevalence of leukemia is contributing to the growth of the leukemia therapeutics market.

Leukemia Therapeutics Market Driver: An Increase In Geriatric Population Is Expected To Fuel The Growth Of The Leukemia Therapeutics Market

The increase in the geriatric population is expected to boost the growth of the leukemia therapeutics market going forward. The geriatric population refers to the percentage of people 65 and older to those between the ages of 18 and 64 who are employed. As the population ages, the heightened risk of developing leukemia and related blood disorders increases the demand for leukemia therapeutics. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. Therefore, the increase in the geriatric population is driving the growth of the leukemia therapeutics market.

Global Leukemia Therapeutics Market Major Players

Major companies operating in the leukemia therapeutics market include Novartis International AG, AbbVie Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Sanofi S. A., Agios Pharmaceuticals, Amgen Inc., Argenx SE, Astellas Pharma Inc., BioLineRx Ltd., Cellerant Therapeutics Inc., Daiichi Sankyo Company Limited, Forma Therapeutics Inc., Gilead Sciences Inc., Incyte Corporation, Jazz Pharmaceuticals plc, Johnson & Johnson, Mirati Therapeutics Inc., Molecular Templates Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Seattle Genetics Inc., Stemline Therapeutics Inc., Sunesis Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, TG Therapeutics Inc., Allogene Therapeutics Inc., Blueprint Medicines Corporation, Karyopharm Therapeutics Inc., Verastem Oncology Inc.

Global Leukemia Therapeutics Market Trend: Strategic Partnerships In The Leukemia Therapeutics Market

Major companies operating in the leukemia therapeutics market are adopting a strategic partnership approach to help the business launch and commercialize its first advanced cancer treatment in the United States. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in February 2023, Xspray Pharma AB, a Sweden-based biotechnology company, partnered with EVERSANA, a US-based company that provides commercial services to the life sciences industry. The partnership aims to facilitate the U.S. launch and commercialization of the company’s first innovative cancer therapy, Dasynoc, intended for treating chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Xspray Pharma will retain financial and strategic control while granting EVERSANA exclusive rights for commercialization to support the Dasynoc launch, scheduled for the second half of 2023.

Global Leukemia Therapeutics Market Trend: Innovative Advancements In The Leukemia Therapeutics Market

Major companies operating in the leukemia therapeutics market are developing innovative products such as Car T therapies to meet larger customer bases, more sales, and increase revenue. Chimeric Antigen Receptor T-cell (CAR-T) therapy is a groundbreaking form of immunotherapy for the treatment of certain types of cancer. For instance, in March 2024, Bristol-Myers Squibb Company, a US-based pharmaceutical company, announced the U. S. Food and Drug Administration (FDA) approval for Breyanzi (lisocabtagene maraleucel; liso-cel). This therapy is a CD19-directed chimeric antigen receptor (CAR) T cell treatment designed for adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have undergone at least two previous lines of therapy, including both a Bruton tyrosine kinase (BTK) inhibitor and a B-cell lymphoma 2 (BCL-2) inhibitor.

Leukemia Therapeutics Market Merger And Acquisition: AstraZeneca Acquired Gracell Biotechnologies

In February 2024, AstraZeneca, a UK-based pharmaceutical company, acquired Gracell Biotechnologies Inc. for an undisclosed amount. The acquisition enhances AstraZeneca’s expanding pipeline of cell therapies by adding GC012F, a novel clinical-stage FasTCAR-enabled autologous chimeric antigen receptor T-cell (CAR-T) therapy that targets both BCMA and CD19. Gracell will function as a wholly owned subsidiary of AstraZeneca, maintaining operations in both China and the United States. Gracell Biotechnologies Inc. is a a China-based biopharmaceutical company that specializes in cell therapies for leukemia and autoimmune diseases.

Regional Outlook For The Global Leukemia Therapeutics Market

North America was the largest region in the leukemia therapeutics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukemia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the leukemia therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

What Defines the Leukemia Therapeutics Market?

The leukemia therapeutics market includes revenues earned by entities by killing fast-growing cancer cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Leukemia Therapeutics Industry?

The leukemia therapeutics market research report is one of a series of new reports from The Business Research Company that provides leukemia therapeutics market statistics, including leukemia therapeutics industry global market size, regional shares, competitors with a leukemia therapeutics market share, detailed leukemia therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the leukemia therapeutics industry. This leukemia therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Leukemia Therapeutics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $18.85 billion
Revenue Forecast In 2034 $25.91 billion
Growth Rate CAGR of 8.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments
2) By Type Of Leukemia: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia
3) By Molecule Type: Small Molecules, Biologics
4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Chemotherapy: Alkylating Agents, Antimetabolites, Plant Alkaloids, Corticosteroids
2) By Immunotherapy: Monoclonal Antibodies, CAR T-Cell Therapy, Immune Checkpoint Inhibitors, Vaccines
3) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), BCL-2 Inhibitors, IDH Inhibitors, Other Targeted Agents
4) By Other Treatments: Radiation Therapy, Stem Cell Transplantation, Supportive Care Treatments
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Novartis International AG, AbbVie Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Sanofi S. A., Agios Pharmaceuticals, Amgen Inc., Argenx SE, Astellas Pharma Inc., BioLineRx Ltd., Cellerant Therapeutics Inc., Daiichi Sankyo Company Limited, Forma Therapeutics Inc., Gilead Sciences Inc., Incyte Corporation, Jazz Pharmaceuticals plc, Johnson & Johnson, Mirati Therapeutics Inc., Molecular Templates Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Seattle Genetics Inc., Stemline Therapeutics Inc., Sunesis Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, TG Therapeutics Inc., Allogene Therapeutics Inc., Blueprint Medicines Corporation, Karyopharm Therapeutics Inc., Verastem Oncology Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Leukemia Therapeutics Market Characteristics

    3. Leukemia Therapeutics Market Trends And Strategies

    4. Leukemia Therapeutics Market- Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Leukemia Therapeutics Growth Analysis And Strategic Analysis Framework

    5.1. Global Leukemia Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Leukemia Therapeutics Market Growth Rate Analysis

    5.4. Global Leukemia Therapeutics Historic Market Size and Growth, 2019- 2024, Value ($ Billion)

    5.5. Global Leukemia Therapeutics Forecast Market Size and Growth, 2024- 2029, 2034F, Value ($ Billion)

    5.6. Global Leukemia Therapeutics Total Addressable Market (TAM)

    6. Leukemia Therapeutics Market Segmentation

    6.1. Global Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Chemotherapy

    Immunotherapy

    Targeted Therapy

    Other Treatments

    6.2. Global Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Acute Lymphocytic Leukemia

    Acute Myeloid Leukemia

    Chronic Lymphocytic Leukemia

    Chronic Myeloid Leukemia

    Other Type Of Leukemia

    6.3. Global Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Small Molecules

    Biologics

    6.4. Global Leukemia Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Homecare

    Specialty Clinics

    Other End-Users

    6.5. Global Leukemia Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Alkylating Agents

    Antimetabolites

    Plant Alkaloids

    Corticosteroids

    6.6. Global Leukemia Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Monoclonal Antibodies

    CAR T-Cell Therapy

    Immune Checkpoint Inhibitors

    Vaccines

    6.7. Global Leukemia Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tyrosine Kinase Inhibitors (TKIs)

    BCL-2 Inhibitors

    IDH Inhibitors

    Other Targeted Agents

    6.8. Global Leukemia Therapeutics Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Radiation Therapy

    Stem Cell Transplantation

    Supportive Care Treatments

    7. Leukemia Therapeutics Market Regional And Country Analysis

    7.1. Global Leukemia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Leukemia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Leukemia Therapeutics Market

    8.1. Asia-Pacific Leukemia Therapeutics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Leukemia Therapeutics Market

    9.1. China Leukemia Therapeutics Market Overview

    9.2. China Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Leukemia Therapeutics Market

    10.1. India Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Leukemia Therapeutics Market

    11.1. Japan Leukemia Therapeutics Market Overview

    11.2. Japan Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Leukemia Therapeutics Market

    12.1. Australia Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Leukemia Therapeutics Market

    13.1. Indonesia Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Leukemia Therapeutics Market

    14.1. South Korea Leukemia Therapeutics Market Overview

    14.2. South Korea Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Leukemia Therapeutics Market

    15.1. Western Europe Leukemia Therapeutics Market Overview

    15.2. Western Europe Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Leukemia Therapeutics Market

    16.1. UK Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Leukemia Therapeutics Market

    17.1. Germany Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Leukemia Therapeutics Market

    18.1. France Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Leukemia Therapeutics Market

    19.1. Italy Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Leukemia Therapeutics Market

    20.1. Spain Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Leukemia Therapeutics Market

    21.1. Eastern Europe Leukemia Therapeutics Market Overview

    21.2. Eastern Europe Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Leukemia Therapeutics Market

    22.1. Russia Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Leukemia Therapeutics Market

    23.1. North America Leukemia Therapeutics Market Overview

    23.2. North America Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Leukemia Therapeutics Market

    24.1. USA Leukemia Therapeutics Market Overview

    24.2. USA Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Leukemia Therapeutics Market

    25.1. Canada Leukemia Therapeutics Market Overview

    25.2. Canada Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Leukemia Therapeutics Market

    26.1. South America Leukemia Therapeutics Market Overview

    26.2. South America Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Leukemia Therapeutics Market

    27.1. Brazil Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Leukemia Therapeutics Market

    28.1. Middle East Leukemia Therapeutics Market Overview

    28.2. Middle East Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Leukemia Therapeutics Market

    29.1. Africa Leukemia Therapeutics Market Overview

    29.2. Africa Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Leukemia Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Leukemia Therapeutics Market Competitive Landscape

    30.2. Leukemia Therapeutics Market Company Profiles

    30.2.1. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Sanofi S. A. Overview, Products and Services, Strategy and Financial Analysis

    31. Leukemia Therapeutics Market Other Major And Innovative Companies

    31.1. Agios Pharmaceuticals

    31.2. Amgen Inc.

    31.3. Argenx SE

    31.4. Astellas Pharma Inc.

    31.5. BioLineRx Ltd.

    31.6. Cellerant Therapeutics Inc.

    31.7. Daiichi Sankyo Company Limited

    31.8. Forma Therapeutics Inc.

    31.9. Gilead Sciences Inc.

    31.10. Incyte Corporation

    31.11. Jazz Pharmaceuticals plc

    31.12. Johnson & Johnson

    31.13. Mirati Therapeutics Inc.

    31.14. Molecular Templates Inc.

    31.15. Ono Pharmaceutical Co. Ltd.

    32. Global Leukemia Therapeutics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Leukemia Therapeutics Market

    34. Recent Developments In The Leukemia Therapeutics Market

    35. Leukemia Therapeutics Market High Potential Countries, Segments and Strategies

    35.1 Leukemia Therapeutics Market In 2029- Countries Offering Most New Opportunities

    35.2 Leukemia Therapeutics Market In 2029- Segments Offering Most New Opportunities

    35.3 Leukemia Therapeutics Market In 2029- Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Leukemia Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Leukemia Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Leukemia Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Leukemia Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Leukemia Therapeutics Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Leukemia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Leukemia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Novartis International AG Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Bristol Myers Squibb Company Financial Performance
  • Table 82: F. Hoffmann-La Roche AG Financial Performance
  • Table 83: Sanofi S. A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Leukemia Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Leukemia Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Leukemia Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Leukemia Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Leukemia Therapeutics Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Leukemia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Leukemia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Leukemia Therapeutics Market, Segmentation By Treatment Of Leukemia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Novartis International AG Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Bristol Myers Squibb Company Financial Performance
  • Figure 82: F. Hoffmann-La Roche AG Financial Performance
  • Figure 83: Sanofi S. A. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the ophthalmology drugs market research report 2022 with industry size, share, segments and market growth

Read More

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer biologics Global Market Report 2025 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rituximab Biosimilars Global Market Report 2025 – By Route Of Administration (Subcutaneous, Intravenous, Molecular Type), By Application (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Mail Order) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Acute Myeloid Leukemia Global Market Report 2025 – By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By End-User (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

CAR-T Therapy Global Market Report 2025 – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, BCMA, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer), By End-User (Hospital, Reference Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the leukemia therapeutics market?

Leukemia therapeutics refer to a treatment used to treat an aggressive (quickly spreading) malignancy in which the blood or bone marrow contain an excessive amount of myeloblasts (immature white blood cells). The type treatment for leukemia depends on various factors such as age, overall health, type of leukemia, its current condition within the body and others. For further insights on the leukemia therapeutics market, request a sample here

How will the leukemia therapeutics market drivers and restraints affect the leukemia therapeutics market dynamics? What forces will shape the leukemia therapeutics industry going forward?

The leukemia therapeutics market major growth driver - The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market. For further insights on the leukemia therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the leukemia therapeutics market?

The leukemia therapeutics market size has grown strongly in recent years. It will grow from $17.57 billion in 2024 to $18.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to growth in geriatric population, improved diagnostics leading to early detection of leukemia, increasing prevalence of leukemia, growing investment in research and development, expansion of personalized medicine approaches. The leukemia therapeutics market size is expected to see strong growth in the next few years. It will grow to $25.91 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to development of novel immunotherapies for leukemia, growing focus on precision medicine in leukemia treatment, expansion of indications for existing leukemia therapies, increased adoption of gene therapies, advances in supportive care for leukemia patients. Major trends in the forecast period include integration of biomarker-driven approaches, rise of combination therapies for enhanced efficacy, emphasis on minimal residual disease monitoring, increasing use of car-t cell therapies, exploration of targeted therapies based on leukemia subtypes. For further insights on the leukemia therapeutics market, request a sample here

How is the leukemia therapeutics market segmented?

The leukemia therapeutics market is segmented
1) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments
2) By Type Of Leukemia: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia
3) By Molecule Type: Small Molecules, Biologics
4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Plant Alkaloids, Corticosteroids
2) By Immunotherapy: Monoclonal Antibodies, CAR T-Cell Therapy, Immune Checkpoint Inhibitors, Vaccines
3) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), BCL-2 Inhibitors, IDH Inhibitors, Other Targeted Agents
4) By Other Treatments: Radiation Therapy, Stem Cell Transplantation, Supportive Care Treatments For further insights on the leukemia therapeutics market, request a sample here

Which region has the largest share of the leukemia therapeutics market? What are the other regions covered in the report?

North America was the largest region in the leukemia therapeutics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukemia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the leukemia therapeutics market, request a sample here.

Who are the major players in the leukemia therapeutics market?

Major companies operating in the leukemia therapeutics market include Novartis International AG, AbbVie Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Sanofi S. A., Agios Pharmaceuticals, Amgen Inc., Argenx SE, Astellas Pharma Inc., BioLineRx Ltd., Cellerant Therapeutics Inc., Daiichi Sankyo Company Limited, Forma Therapeutics Inc., Gilead Sciences Inc., Incyte Corporation, Jazz Pharmaceuticals plc, Johnson & Johnson, Mirati Therapeutics Inc., Molecular Templates Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Seattle Genetics Inc., Stemline Therapeutics Inc., Sunesis Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, TG Therapeutics Inc., Allogene Therapeutics Inc., Blueprint Medicines Corporation, Karyopharm Therapeutics Inc., Verastem Oncology Inc. For further insights on the leukemia therapeutics market, request a sample here.

What are the key trends in the leukemia therapeutics market?

Major trend in the leukemia therapeutics market - Strategic Partnerships In The Leukemia Therapeutics Market . For further insights on the leukemia therapeutics market, request a sample here.

What are the major opportunities in the leukemia therapeutics market? What are the strategies for the leukemia therapeutics market?

For detailed insights on the major opportunities and strategies in the leukemia therapeutics market, request a sample here.

How does the leukemia therapeutics market relate to the overall economy and other similar markets?

For detailed insights on leukemia therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the leukemia therapeutics industry?

For detailed insights on the mergers and acquisitions in the leukemia therapeutics industry, request a sample here.

What are the key dynamics influencing the leukemia therapeutics market growth? SWOT analysis of the leukemia therapeutics market.

For detailed insights on the key dynamics influencing the leukemia therapeutics market growth and SWOT analysis of the leukemia therapeutics industry, request a sample here.